|
ARL6IP6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.754000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.719900E-03 |
| Normal-vs-Stage2 |
1.970430E-01 |
| Normal-vs-Stage3 |
8.373700E-02 |
| Normal-vs-Stage4 |
3.031600E-01 |
| Stage1-vs-Stage2 |
1.304870E-03 |
| Stage1-vs-Stage3 |
5.423400E-01 |
| Stage1-vs-Stage4 |
2.282800E-01 |
| Stage2-vs-Stage3 |
1.171920E-02 |
| Stage2-vs-Stage4 |
4.812400E-02 |
| Stage3-vs-Stage4 |
6.064600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.623500E-03 |
| Normal-vs-AfricanAmerican |
1.290820E-01 |
| Normal-vs-Asian |
5.184100E-02 |
| Caucasian-vs-AfricanAmerican |
9.440800E-01 |
| Caucasian-vs-Asian |
8.571000E-01 |
| AfricanAmerican-vs-Asian |
9.524000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.309400E-01 |
| Normal-vs-Female |
1.805820E-02 |
| Male-vs-Female |
3.690600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.404800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.520760E-01 |
| Normal-vs-Age(61-80Yrs) |
9.468800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.156200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.561900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.439300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.585000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.727610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.910400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.733200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.573400E-01 |
| Classical-VS-Follicular |
9.95048488050543E-12 |
| Classical-VS-Other |
6.769600E-01 |
| Classical-VS-Normal |
2.787500E-04 |
| Tall-VS-Follicular |
4.33509999997472E-06 |
| Tall-VS-Other |
9.815200E-01 |
| Tall-VS-Normal |
1.485550E-02 |
| Follicular-VS-Other |
8.644400E-03 |
| Follicular-VS-Normal |
4.420200E-03 |
| Other-VS-Normal |
2.284800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.313800E-01 |
| Normal-vs-N1 |
8.768000E-02 |
| N0-vs-N1 |
1.141410E-01 |
|
|
